India's Pharma Exports Rise 4.9% in H1 FY27 Led by Europe and ASEAN Growth
India's pharmaceutical exports grew 4.9% year-on-year to $16.14 billion in the first half of FY27, driven by increased shipments to Europe, ASEAN, Latin America, and Africa, which offset a decline in shipments to the US. Europe accounted for over one-fifth of total exports with nearly 10% growth, led by Germany, the Netherlands, and France. Key product categories such as drug formulations, biologicals, bulk drugs, and surgical products all saw growth. The sector also experienced a 23% rise in deal volumes in Q3 2026, reflecting ongoing market activity.
First-hand measurement across 5 sources
We measured how 5 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (65/100). Lens Score 39/100.
Outlets measured: moneycontrol, thehindu, economictimes, businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 29 Oct, 01:46 pm. Other outlets followed.